Largest biotech by net assets

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Gilead Sciences leads the 24 biotech ranked by net assets, at SEK 230.9B, ahead of BioNTech (SEK 216.9B) and Biogen (SEK 185.7B). Figures as of 18 Nov 2026, 14:23 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
Gilead SciencesSEK 230.9B
Median
SEK 20.5B
Combined market value
SEK 8.64T
Countries
5

Market values as of .

Largest biotech by net assets
#CompanyNet assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Gilead SciencesGILD · Health CareSEK 230.9BSEK 2.15TSEK 1,731.70 1.60% up 33% up United States
2BioNTechBNTX · Health CareSEK 216.9BSEK 214BSEK 863.10 0.47% down 16% down Germany
3BiogenBIIB · Health CareSEK 185.7BSEK 377.1BSEK 2,550.76 0.34% down 49% up United States
4AmgenAMGN · Health CareSEK 88.1BSEK 2.52TSEK 4,657.56 0.95% down 34% up United States
5ModernaMRNA · Health CareSEK 88BSEK 851.1BSEK 2,103.34 3.93% down 755% up United States
6argenxARGX · Health CareSEK 74.5BSEK 606BSEK 9,637.14 0.36% down 4% up Belgium
7QiagenQGEN · Health CareSEK 38.4BSEK 104.5BSEK 506.00 0.12% down 12% up Netherlands
8Neurocrine BiosciencesNBIX · Health CareSEK 33.1BSEK 170.8BSEK 1,687.56 0.37% up 20% up United States
9VaxcytePCVX · Health CareSEK 27.3BSEK 95.6BSEK 604.15 3.59% down 22% up United States
10ExelixisEXEL · Health CareSEK 22BSEK 170BSEK 696.71 2.09% up 63% up United States
11Bio-TechneTECH · Health CareSEK 21.4BSEK 116BSEK 738.71 0.22% down 26% up United States
12RepligenRGEN · Health CareSEK 21.4BSEK 105.4BSEK 1,649.52 0.37% down 5% up United States
13CRISPR TherapeuticsCRSP · Health CareSEK 19.5BSEK 39.6BSEK 408.36 0.54% down 21% down Switzerland
14Revolution MedicinesRVMD · Health CareSEK 16.6BSEK 357.9BSEK 1,654.71 2.50% down 131% up United States
15Kymera TherapeuticsKYMR · Health CareSEK 16.1BSEK 105.5BSEK 1,235.97 3.44% down 87% up United States
16Krystal BiotechKRYS · Health CareSEK 12.4BSEK 90BSEK 3,036.53 0.22% up 46% up United States
17ImmunovantIMVT · Health CareSEK 8.7BSEK 69.9BSEK 337.78 0.21% down 43% up United States
18CG OncologyCGON · Health CareSEK 7.7BSEK 71.7BSEK 802.89 6.89% down 85% up United States
19Twist BioscienceTWST · Health CareSEK 4.8BSEK 77.7BSEK 1,139.14 6.63% up 340% up United States
20Scholar Rock HoldingSRRK · Health CareSEK 2.5BSEK 55.9BSEK 458.50 1.21% up 14% up United States
21Adaptive BiotechnologiesADPT · Health CareSEK 2.2BSEK 46.9BSEK 289.77 2.22% up 88% up United States
22Kodiak SciencesKOD · Health CareSEK 1.6BSEK 64.4BSEK 984.54 3.90% down 396% up United States
23Halozyme TherapeuticsHALO · Health CareSEK 496.5MSEK 111.3BSEK 976.10 0.55% down 37% up United States
24ImmunityBioIBRX · Health Care-SEK 5.1BSEK 67.7BSEK 63.67 4.68% up 193% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1709 SEK).

Questions and answers

Which biotech rank first by net assets?

Gilead Sciences (SEK 230.9B), BioNTech (SEK 216.9B) and Biogen (SEK 185.7B) are the top three of the 24 biotech ranked by net assets as of 18 Nov 2026, 14:23 UTC.

How many biotech are in this ranking?

24 are ranked by net assets.

What are these biotech worth together?

The 24 biotech ranked by net assets have a combined market value of SEK 8.64T as of 18 Nov 2026, 14:23 UTC.

What does ranking by net assets measure?

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Cite this page

Funkfolio, “Largest biotech by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=net-assets

Underlying data: Yahoo Finance; SEC EDGAR.